# Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer

> **NCT00989105** · PHASE1 · TERMINATED · sponsor: **Cancer Research UK** · enrollment: 8 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **OTHER:** pharmacological study
- **PROCEDURE:** computed tomography
- **PROCEDURE:** magnetic resonance imaging
- **PROCEDURE:** single photon emission computed tomography
- **RADIATION:** technetium Tc 99m demobesin-4

## Key facts

- **NCT ID:** NCT00989105
- **Lead sponsor:** Cancer Research UK
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00989105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00989105, "Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00989105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*